SYMBICORT Brand Expands RCR Partnership in 2019

Richard Childress Racing is pleased to announce the expansion of its partnership with AstraZeneca’s SYMBICORT® (budesonide/formoterol fumarate dihydrate) brand for the 2019 Monster Energy NASCAR Cup Series season. The SYMBICORT brand will return as a multi-race primary partner on Austin Dillion’s No. 3 Chevrolet Camaro ZL1, and will also serve as the primary partner on Tyler Reddick’s No. 31 Chevrolet Camaro ZL1 for the 2019 DAYTONA 500.

 

“We’re looking forward to having the SYMBICORT brand back with RCR for our 50th Anniversary celebration in an expanded role, as it is a special partnership to many of us,” said Torrey Galida, President of RCR. “We’re grateful to have their support for both Austin’s 2019 season, as well as Tyler’s first DAYTONA 500. That is a huge milestone for any young driver and to be able to represent a brand like SYMBICORT makes the event even more special.”

 

AstraZeneca is a global science-based biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicine. More information about SYMBICORT can be found at MySymbicort.com.

 

For additional information on today’s announcement, and all that’s happening at RCR, please visit rcrracing.com.

 

RCR PR